Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

被引:534
作者
Page, Matthew J. [1 ]
McKenzie, Joanne E. [1 ]
Bossuyt, Patrick M. [2 ]
Boutron, Isabelle [3 ]
Hoffmann, Tammy C. [4 ]
Mulrow, Cynthia D. [5 ]
Shamseer, Larissa [6 ]
Tetzlaff, Jennifer M. [7 ]
Moher, David [6 ,8 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[2] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands
[3] Univ Paris, Ctr Epidemiol & Stat CRESS, INSERM, F-75004 Paris, France
[4] Bond Univ, Inst Evidence Based Healthcare, Fac Hlth Sci & Med, Gold Coast, Australia
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada
[7] Evidence Partners, Ottawa, ON, Canada
[8] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会;
关键词
Systematic reviews; Meta-analysis; Reporting guidelines; Transparency; Reproducibility; EXTENSION STATEMENT; METAANALYSIS; TRIAL; INTERVENTIONS; ACCURACY; IMPACT; TOOL;
D O I
10.1016/j.jclinepi.2021.02.003
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To describe the processes used to update the PRISMA 2009 statement for reporting systematic reviews, present results of a survey conducted to inform the update, summarize decisions made at the PRISMA update meeting, and describe and justify changes made to the guideline.& nbsp; Methods: We reviewed 60 documents with reporting guidance for systematic reviews to generate suggested modifications to the PRISMA 2009 statement. We invited 220 systematic review methodologists and journal editors to complete a survey about the suggested modifications. The results of these projects were discussed at a 21-member in-person meeting. Following the meeting, we drafted the PRISMA 2020 statement and refined it based on feedback from co-authors and a convenience sample of 15 systematic reviewers.& nbsp; Results: The review of 60 documents revealed that all topics addressed by the PRISMA 2009 statement could be modified. Of the 110 survey respondents, more than 66% recommended keeping six of the original checklist items as they were and modifying 15 of them using wording suggested by us. Attendees at the in-person meeting supported the revised wording for several items but suggested rewording for most to enhance clarity, and further refinements were made over six drafts of the guideline.& nbsp; Conclusions: The PRISMA 2020 statement consists of updated reporting guidance for systematic reviews. We hope that providing this detailed description of the development process will enhance the acceptance and uptake of the guideline and assist those developing and updating future reporting guidelines. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:103 / 112
页数:10
相关论文
共 40 条
[31]  
Schlussel, 2020, STRENGTHENING METHOD
[32]  
Schulz KF, 2010, TRIALS, V11, DOI [10.1186/1745-6215-11-32, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18, 10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1097/AOG.0b013e3181d9d421, 10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c332, 10.1016/j.jclinepi.2010.02.005]
[33]   Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance [J].
Sones, William ;
Julious, Steven A. ;
Rothwell, Joanne C. ;
Ramsay, Craig Robert ;
Hampson, Lisa V. ;
Emsley, Richard ;
Walters, Stephen J. ;
Hewitt, Catherine ;
Bland, Martin ;
Fergusson, Dean A. ;
Berlin, Jesse A. ;
Altman, Doug ;
Vale, Luke David ;
Cook, Jonathan Alistair .
TRIALS, 2018, 19
[34]  
Stevens A., PRISMA RR 2017 EXTEN
[35]   Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement [J].
Stewart, Lesley A. ;
Clarke, Mike ;
Rovers, Maroeska ;
Riley, Richard D. ;
Simmonds, Mark ;
Stewart, Gavin ;
Tierney, Jayne F. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (16) :1657-1665
[36]  
STOVOLD E, 2014, INT J SURG, V3, P54
[37]  
Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
[38]  
von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297, 10.1016/S0140-6736(07)61602-X]
[39]   PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity [J].
Welch, Vivian ;
Petticrew, Mark ;
Tugwell, Peter ;
Moher, David ;
O'Neill, Jennifer ;
Waters, Elizabeth ;
White, Howard .
PLOS MEDICINE, 2012, 9 (10)
[40]   PRISMA harms checklist: improving harms reporting in systematic reviews [J].
Zorzela, Liliane ;
Loke, Yoon K. ;
Ioannidis, John P. ;
Golder, Su ;
Santaguida, Pasqualina ;
Altman, Douglas G. ;
Moher, David ;
Vohra, Sunita .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 352